LY 03020
Alternative Names: LY-03020Latest Information Update: 30 Sep 2024
Price :
$50 *
At a glance
- Originator Luye Pharma Group
- Class Antidementias; Small molecules
- Mechanism of Action 5-HT2C serotonin receptor agonists; Trace amine-associated receptor 1 agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Alzheimer's disease